PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28170200-3	2017	The objective of the present study was to detect whether overexpression of methylglyoxal-metabolizing enzyme glyoxalase-1 (GLO1), which reduces ROS in D-ADSCs, can restore their proangiogenic function in a streptozotocin-induced diabetic mice model of CLI.	Reactive Oxygen Species	144-147	glyoxalase 1	Mus musculus	109-121	
28170200-3	2017	The objective of the present study was to detect whether overexpression of methylglyoxal-metabolizing enzyme glyoxalase-1 (GLO1), which reduces ROS in D-ADSCs, can restore their proangiogenic function in a streptozotocin-induced diabetic mice model of CLI.	Reactive Oxygen Species	144-147	glyoxalase 1	Mus musculus	123-127	
28170200-11	2017	The results of the present study have demonstrated that protection from ROS accumulation by GLO1 overexpression is effective in reversing the impaired biological function of D-ADSCs in promoting neovascularization of diabetic CLI mice model and warrants the future clinical application of D-ADSC-based therapy in diabetic patients.	Reactive Oxygen Species	72-75	glyoxalase 1	Mus musculus	92-96	
19833897-11	2010	This effect is mediated by ROS-induced methylglyoxal, the major substrate of glyoxalase 1.	Reactive Oxygen Species	27-30	glyoxalase 1	Mus musculus	77-89